Pre-Operative, Single-Dose Ipilimumab and/or Cryoablation in Early Stage/Resectable Breast Cancer

NCT01502592 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Invasive Adenocarcinoma of the Breast

Interventions

PROCEDURE: Cryoablation
BIOLOGICAL: Ipilimumab

Sponsor

Memorial Sloan Kettering Cancer Center